229 related articles for article (PubMed ID: 16799769)
21. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
Komen JC; Duran M; Wanders RJ
Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of oxidation from phytol to phytanic acid in man.
Wierzbicki AS
Mol Genet Metab; 2004 Dec; 83(4):347. PubMed ID: 15589124
[No Abstract] [Full Text] [Related]
23. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
24. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
25. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata.
Brites P; Motley AM; Gressens P; Mooyer PA; Ploegaert I; Everts V; Evrard P; Carmeliet P; Dewerchin M; Schoonjans L; Duran M; Waterham HR; Wanders RJ; Baes M
Hum Mol Genet; 2003 Sep; 12(18):2255-67. PubMed ID: 12915479
[TBL] [Abstract][Full Text] [Related]
26. The chemical biology of branched-chain lipid metabolism.
Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
[TBL] [Abstract][Full Text] [Related]
27. Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation.
Khalil Y; Carrino S; Lin F; Ferlin A; Lad HV; Mazzacuva F; Falcone S; Rivers N; Banks G; Concas D; Aguilar C; Haynes AR; Blease A; Nicol T; Al-Shawi R; Heywood W; Potter P; Mills K; Gale DP; Clayton PT
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055171
[TBL] [Abstract][Full Text] [Related]
28. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
[TBL] [Abstract][Full Text] [Related]
29. Assay for Sjögren-Larsson syndrome based on a deficiency of phytol degradation.
van den Brink DM; van Miert JM; Wanders RJ
Clin Chem; 2005 Jan; 51(1):240-2. PubMed ID: 15613721
[No Abstract] [Full Text] [Related]
30. Phytanic acid alpha-oxidation, new insights into an old problem: a review.
Wanders RJ; Jansen GA; Lloyd MD
Biochim Biophys Acta; 2003 Mar; 1631(2):119-35. PubMed ID: 12633678
[TBL] [Abstract][Full Text] [Related]
31. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
Skjeldal OH; Stokke O
Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
[TBL] [Abstract][Full Text] [Related]
32. Phytanic acid consumption and human health, risks, benefits and future trends: A review.
Roca-Saavedra P; Mariño-Lorenzo P; Miranda JM; Porto-Arias JJ; Lamas A; Vazquez BI; Franco CM; Cepeda A
Food Chem; 2017 Apr; 221():237-247. PubMed ID: 27979198
[TBL] [Abstract][Full Text] [Related]
33. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.
Watkins PA; Howard AE; Gould SJ; Avigan J; Mihalik SJ
J Lipid Res; 1996 Nov; 37(11):2288-95. PubMed ID: 8978480
[TBL] [Abstract][Full Text] [Related]
34. Phytol-induced pathology in 2-hydroxyacyl-CoA lyase (HACL1) deficient mice. Evidence for a second non-HACL1-related lyase.
Mezzar S; De Schryver E; Asselberghs S; Meyhi E; Morvay PL; Baes M; Van Veldhoven PP
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):972-990. PubMed ID: 28629946
[TBL] [Abstract][Full Text] [Related]
35. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation.
Gloerich J; Ruiter JP; van den Brink DM; Ofman R; Ferdinandusse S; Wanders RJ
FEBS Lett; 2006 Apr; 580(8):2092-6. PubMed ID: 16546181
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
[TBL] [Abstract][Full Text] [Related]
37. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.
Lloyd MD; Mukherji M; Kershaw NJ; Chien W; Wierzbicki AS; Schofield CJ
Adv Exp Med Biol; 2003; 544():303-4. PubMed ID: 14713244
[No Abstract] [Full Text] [Related]
38. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
Watkins PA; Mihalik SJ
Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
[TBL] [Abstract][Full Text] [Related]
39. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
Xu F; Ng VY; Kroetz DL; de Montellano PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
[TBL] [Abstract][Full Text] [Related]
40. The subcellular localization of phytanic acid oxidase in rat liver.
Skjeldal OH; Stokke O
Biochim Biophys Acta; 1987 Sep; 921(1):38-42. PubMed ID: 3620488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
